Results 111 to 120 of about 52,972 (303)

Is tremor in dystonia a phenotypic feature of dystonia?

, 2015
To understand better the features and mechanisms distinguishing tremor in dystonia, we reviewed the epidemiologic, clinical, and neurophysiologic data in patients with dystonia and tremor.
DEFAZIO, GIOVANNI, FABBRINI, Giovanni, Defazio G, Gigante, Angelo F., Gigante AF, BERARDELLI, Alfredo, CONTE, ANTONELLA   +6 more
core   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Effects of botulinum neurotoxin on regularity of head oscillations in cervical dystonia

Dystonia
Introduction: This study explores the effects of botulinum neurotoxin (BoNT) on the relationship between dystonia and tremor, specifically focusing on cervical dystonia (CD) and its connection to head tremor.Methods: Fourteen CD patients were recruited ...
Hanieh Agharazi, H. A. Jinnah, David S. Zee, Aasef G. Shaikh, Aasef G. Shaikh, Aasef G. Shaikh   +5 more
doaj   +1 more source

CLINICAL PHENOMENOLOGY OF DYSTONIA

, 2011
Dystonia is defined as a motor syndrome characterized by sustained muscle contractions, usually producing twisting and repetitive movements or abnormal postures. Dystonia can be present at rest or worsened by action.
Alfredo Berardelli, COLOSIMO, Carlo, BERARDELLI, Alfredo, Carlo Colosimo   +3 more
core   +1 more source

DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA for injection (DAXI), a novel botulinum toxin (BoNT) formulated with a custom‐engineered peptide, was recently approved for treating cervical dystonia (CD). DAXI demonstrated a long duration of symptom relief in Phase 3 trials. Objective To report findings from PrevU, an early experience, real‐world observational
Laxman Bahroo, Aaron Ellenbogen, Robert A. Hauser, Han S. Lee, Peter McAllister, Atul T. Patel, Rashid Kazerooni, Todd M. Gross, Julia Sparrow, Conor J. Gallagher, David A. Hollander   +10 more
wiley   +1 more source

Functional connectivity of brain areas related to social cognition and anxiety in cervical dystonia

Dystonia
IntroductionRecent studies highlighted the importance of non-motor symptoms, including emotional processing dysfunction, in individuals with cervical dystonia (CD).
Veronica Guadagni, Veronica Guadagni, Ford Burles, Brandy L. Callahan, Giuseppe Iaria, Davide Martino   +5 more
doaj   +1 more source

Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A

, 2015
Reversa R Mills, Fernando L Pagan Department of Neurology, Movement Disorders and Neurorestoration Division, Georgetown University Hospital, Washington, DC, USA Abstract: Cervical dystonia is the most common form of focal dystonia characterized by
Mills RR, Pagan FL
core  

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Efficacy and safety of valbenazine in the treatment of cervical dystonia: a pilot study

Dystonia
BackgroundVesicular monoamine transporter-2 inhibitors have provided on-label success in the treatment of tardive dyskinesia (TD) and Huntington’s disease chorea (HDC). A similar pathophysiological pathway for cervical dystonia suggests valbenazine (VBZ)
Salma Aziz, Erin Pellot, Laxman Bahroo, Abhishek Wajpe, Martin T. Taylor   +4 more
doaj   +1 more source